C12Y 207/01074
Deoxycytidine kinase
Official title: Deoxycytidine kinase (2.7.1.74)
C12Y207/01074 (Deoxycytidine kinase) appears on 3 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 7
- Assignees
- 7
- Inventors
- 18
- Latest grant
- 13 Dec 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 3 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
By publication year.
Recent patents
- Lentiviral-based vector and its use in directed evolution of genomic regions, genes and polynucleotides13 Dec 2016US 9,518,271 B2Centre National De La Recherche Scientifique
- Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy14 Jun 2016US 9,364,494 B2Cayla
- Methods for improving and managing nucleoside reverse-transcriptase inhibition based treatment10 May 2016US 9,334,524 B2Amikana, Biologics
- Mutant human deoxycytidine kinase26 Apr 2018US 2018/0112194 A1Centre National De La Recherche Scientifique
- Lentiviral-based vector and its use in directed evolution of genomic regions, genes and polynucleotides16 Mar 2017US 2017/0073672 A1Centre National De La Recherche Scientifique
- Combination products for treating cancer9 Jul 2015US 2015/0190480 A1Cayla
- Methods for improving and managing nucleoside reverse-transcriptase inhibition based treatment22 May 2014US 2014/0141461 A1Amikana, Biologics
- Lentiviral-based vector and its use in directed evolution of genomic regions, genes and polynucleotides18 Oct 2012US 2012/0264616 A1Centre National De La Recherche Scientifique
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.